FOX
60
-10
AON
65
-2
DLTR
64
-2
EMC
54
-2
PSA
46
-5
SNA
50
-3
EL
58
5
INTU
63
7
ADBE
52
-4
HD
31
-3
MCO
64
2
GD
57
-3
PCG
67
-2
ICE
60
-4
SLB
42
-4
DG
72
2
FRT
58
-2
ADM
44
-7
AZO
43
-5
FLR
40
-2
FOX
60
-10
AON
65
-2
DLTR
64
-2
EMC
54
-2
PSA
46
-5
SNA
50
-3
EL
58
5
INTU
63
7
ADBE
52
-4
HD
31
-3
MCO
64
2
GD
57
-3
PCG
67
-2
ICE
60
-4
SLB
42
-4
DG
72
2
FRT
58
-2
ADM
44
-7
AZO
43
-5
FLR
40
-2
Financhill
Back

Evolv Technologies Holdings, Inc. Vs. Nektar Therapeutics Industry Stock Comparison

Sell
43

EVLV
Evolv Technologies Holdings, Inc.

Last Price:
$6.93
Seasonality Move:
-21.4%
Sell
42

NKTR
Nektar Therapeutics

Last Price:
$44.85
Seasonality Move:
11.58%
Sell
43
Evolv Technologies Holdings, Inc. (EVLV) is a Sell

Is Evolv Technologies Holdings, Inc. a Buy, Sell or Hold?

  • The current Evolv Technologies Holdings, Inc. [EVLV] share price is $6.86. The Score for EVLV is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • EVLV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EVLV Stock Price Chart

What is Evolv Technologies Holdings, Inc.'s stock price today?

  • The Evolv Technologies Holdings, Inc. share price today is $6.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EVLV is experiencing buying pressure, which is a positive indicator for future bullish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $49.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

EVLV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 53.43 Buy
Chaikin Money Flow: 985832 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 38.92 Sell
Chaikin Money Flow: 341847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

EVLV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.77 Buy
20-day SMA: 6.42 Buy
50-day SMA: 7.11 Sell
200-day SMA: 6.01 Buy
8-day EMA: 6.75 Buy
20-day EMA: 6.67 Buy
50-day EMA: 6.92 Sell
200-day EMA: 6.27 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.87 Sell
20-day SMA: 57.43 Sell
50-day SMA: 58.05 Sell
200-day SMA: 31.04 Buy
8-day EMA: 54.11 Sell
20-day EMA: 56.28 Sell
50-day EMA: 55.42 Sell
200-day EMA: 38.13 Buy

Evolv Technologies Holdings, Inc. Earnings Growth & EVLV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and an increase next year of $0.04 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Evolv Technologies Holdings, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):